Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain

D. H. Crouch, F. Fisher, S. A. La Rocca, C. R. Goding, D. A. F. Gillespie

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    THE SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PLEASE REFER TO THE ABSTRACT ON THE PUBLISHER'S WEBSITE FOR AN ACCURATE DISPLAY. Interaction with Max via the helix–loop–helix/leucine zipper (HLH-LZ) domain is essential for Myc to function as a transcription factor. Myc is commonly upregulated in tumours, however, its activity can also be potentiated by virally derived mutations. vMyc, derived from the virus, MC29 gag-Myc, differs from its cellular counterpart by five amino acids. The N-terminal mutation stabilizes the protein, however, the significance of the other mutations is not known. We now show that vMyc can sustain longer deletions in the LZ domain than cMyc before complete loss in transforming activity, implicating the viral mutations in contributing to Myc:Max complex formation. We confirmed this both in vitro and in vivo, with loss of Max binding correlating with a loss in the biological activity of Myc. A specific viral mutation, isoleucine383>leucine (I383>L) in helix 2 of the HLH domain, extends the LZ domain from four to five heptad repeats. Significantly, introduction of I383>L into a Myc mutant that is defective for Max binding substantially restored its ability to complex with Max in vitro and in vivo. We therefore propose that this virally derived mutation is functional by significantly contributing to establishing amorehydrophobic interface between the LZs of Myc and Max.
    Original languageEnglish
    Pages (from-to)5235-5242
    Number of pages8
    JournalNucleic Acids Research
    Volume33
    Issue number16
    DOIs
    Publication statusPublished - Sep 2005

    Fingerprint

    Leucine Zippers
    Mutation
    Leucine
    Transcription Factors
    Viruses
    Amino Acids
    Neoplasms
    Proteins

    Cite this

    Crouch, D. H., Fisher, F., La Rocca, S. A., Goding, C. R., & Gillespie, D. A. F. (2005). Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain. Nucleic Acids Research, 33(16), 5235-5242. https://doi.org/10.1093/nar/gki832
    Crouch, D. H. ; Fisher, F. ; La Rocca, S. A. ; Goding, C. R. ; Gillespie, D. A. F. / Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain. In: Nucleic Acids Research. 2005 ; Vol. 33, No. 16. pp. 5235-5242.
    @article{9498fc00032a4448bf29452c39d7c18c,
    title = "Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain",
    abstract = "THE SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PLEASE REFER TO THE ABSTRACT ON THE PUBLISHER'S WEBSITE FOR AN ACCURATE DISPLAY. Interaction with Max via the helix–loop–helix/leucine zipper (HLH-LZ) domain is essential for Myc to function as a transcription factor. Myc is commonly upregulated in tumours, however, its activity can also be potentiated by virally derived mutations. vMyc, derived from the virus, MC29 gag-Myc, differs from its cellular counterpart by five amino acids. The N-terminal mutation stabilizes the protein, however, the significance of the other mutations is not known. We now show that vMyc can sustain longer deletions in the LZ domain than cMyc before complete loss in transforming activity, implicating the viral mutations in contributing to Myc:Max complex formation. We confirmed this both in vitro and in vivo, with loss of Max binding correlating with a loss in the biological activity of Myc. A specific viral mutation, isoleucine383>leucine (I383>L) in helix 2 of the HLH domain, extends the LZ domain from four to five heptad repeats. Significantly, introduction of I383>L into a Myc mutant that is defective for Max binding substantially restored its ability to complex with Max in vitro and in vivo. We therefore propose that this virally derived mutation is functional by significantly contributing to establishing amorehydrophobic interface between the LZs of Myc and Max.",
    author = "Crouch, {D. H.} and F. Fisher and {La Rocca}, {S. A.} and Goding, {C. R.} and Gillespie, {D. A. F.}",
    note = "dc.publisher: Oxford University Press dc.description.sponsorship: Cancer Research UK Association for International Cancer Research",
    year = "2005",
    month = "9",
    doi = "10.1093/nar/gki832",
    language = "English",
    volume = "33",
    pages = "5235--5242",
    journal = "Nucleic Acids Research",
    issn = "0305-1048",
    publisher = "Oxford University Press",
    number = "16",

    }

    Crouch, DH, Fisher, F, La Rocca, SA, Goding, CR & Gillespie, DAF 2005, 'Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain', Nucleic Acids Research, vol. 33, no. 16, pp. 5235-5242. https://doi.org/10.1093/nar/gki832

    Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain. / Crouch, D. H.; Fisher, F.; La Rocca, S. A.; Goding, C. R.; Gillespie, D. A. F.

    In: Nucleic Acids Research, Vol. 33, No. 16, 09.2005, p. 5235-5242.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain

    AU - Crouch, D. H.

    AU - Fisher, F.

    AU - La Rocca, S. A.

    AU - Goding, C. R.

    AU - Gillespie, D. A. F.

    N1 - dc.publisher: Oxford University Press dc.description.sponsorship: Cancer Research UK Association for International Cancer Research

    PY - 2005/9

    Y1 - 2005/9

    N2 - THE SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PLEASE REFER TO THE ABSTRACT ON THE PUBLISHER'S WEBSITE FOR AN ACCURATE DISPLAY. Interaction with Max via the helix–loop–helix/leucine zipper (HLH-LZ) domain is essential for Myc to function as a transcription factor. Myc is commonly upregulated in tumours, however, its activity can also be potentiated by virally derived mutations. vMyc, derived from the virus, MC29 gag-Myc, differs from its cellular counterpart by five amino acids. The N-terminal mutation stabilizes the protein, however, the significance of the other mutations is not known. We now show that vMyc can sustain longer deletions in the LZ domain than cMyc before complete loss in transforming activity, implicating the viral mutations in contributing to Myc:Max complex formation. We confirmed this both in vitro and in vivo, with loss of Max binding correlating with a loss in the biological activity of Myc. A specific viral mutation, isoleucine383>leucine (I383>L) in helix 2 of the HLH domain, extends the LZ domain from four to five heptad repeats. Significantly, introduction of I383>L into a Myc mutant that is defective for Max binding substantially restored its ability to complex with Max in vitro and in vivo. We therefore propose that this virally derived mutation is functional by significantly contributing to establishing amorehydrophobic interface between the LZs of Myc and Max.

    AB - THE SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PLEASE REFER TO THE ABSTRACT ON THE PUBLISHER'S WEBSITE FOR AN ACCURATE DISPLAY. Interaction with Max via the helix–loop–helix/leucine zipper (HLH-LZ) domain is essential for Myc to function as a transcription factor. Myc is commonly upregulated in tumours, however, its activity can also be potentiated by virally derived mutations. vMyc, derived from the virus, MC29 gag-Myc, differs from its cellular counterpart by five amino acids. The N-terminal mutation stabilizes the protein, however, the significance of the other mutations is not known. We now show that vMyc can sustain longer deletions in the LZ domain than cMyc before complete loss in transforming activity, implicating the viral mutations in contributing to Myc:Max complex formation. We confirmed this both in vitro and in vivo, with loss of Max binding correlating with a loss in the biological activity of Myc. A specific viral mutation, isoleucine383>leucine (I383>L) in helix 2 of the HLH domain, extends the LZ domain from four to five heptad repeats. Significantly, introduction of I383>L into a Myc mutant that is defective for Max binding substantially restored its ability to complex with Max in vitro and in vivo. We therefore propose that this virally derived mutation is functional by significantly contributing to establishing amorehydrophobic interface between the LZs of Myc and Max.

    U2 - 10.1093/nar/gki832

    DO - 10.1093/nar/gki832

    M3 - Article

    VL - 33

    SP - 5235

    EP - 5242

    JO - Nucleic Acids Research

    JF - Nucleic Acids Research

    SN - 0305-1048

    IS - 16

    ER -

    Crouch DH, Fisher F, La Rocca SA, Goding CR, Gillespie DAF. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain. Nucleic Acids Research. 2005 Sep;33(16):5235-5242. https://doi.org/10.1093/nar/gki832